Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)

Clinical trial NCT00485758 · COMPLETED

Trial details

NCT number: NCT00485758
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2007-07-01
Primary completion: 2008-08-01
Enrollment: 796

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.